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Abstract: Detailed knowledge of the three-dimensional (3D) structure of a protein is essential for the proper understanding of its
function(s) that could be modified through posttranslational modifications (PTMs). Among these PTMs, alterations of serine/threonine
residues of a protein through phosphorylation and O-glycosylation are extremely dynamic and could modulate the functions of a
protein by affecting their 3D structure. Potential of a protein for certain PTMs could be evaluated through computer-based methods.
Erythropoietin (EPO) is a multifunctional protein that primarily regulates red blood cell production and is also involved in other
nonhematopoietic functions; for example, EPO also has cardioprotective and neuroprotective effects. In this study, multifunctional EPO
behavior has been revealed based on transient modifications of its receptor. In this study, PTMs of erythropoietin receptor (EPO-R) were
predicted using neural network tools, and the possible effects of these modifications are suggested. Phosphorylation and O-glycosylation
at serine 380 and 444 of the cytoplasmic domain of EPO-R seem to have an antagonistic role in controlling signaling events induced by
EPO. O-glycosylation at threonine 423 might hinder β-TrCP (a ubiquitin ligase) binding, which ubiquitinates at K 428, and ultimately
results in the recycling of EPO-R, thus increasing EPO sensitivity. In contrast, the phosphorylated form of the same residue inhibits the
recycling of EPO-R and thereby decreases the EPO sensitivity. Additionally, the interplay of O-glycosylation modification at serine 478
and phosphorylation at tyrosine 479 might help in controlling the duration of EPO-induced signaling.
Key words: EPO receptor, phosphorylation, O-glycosylation, three-dimensional (3D) structure, multifunctional behavior and EPO

1. Introduction

Cytokines are a diverse family of small, secreted
glycoproteins that performs multiple functions, including
growth regulation, differentiation, and cell proliferation
(Tyson et al., 2001). Hematopoietic cytokines are one of
the important groups involved in both hematopoietic
and nonhematopoietic cell regulation and differentiation
(Bazan, 1991). Among all the hematopoietic cytokines,
erythropoietin (EPO) is an essential cytokine necessary
for the differentiation, proliferation, and maintenance
of stem cells that produce red blood cells (Jelkmann,
1992a, 2011b). EPO action is mediated through its
binding to a speciﬁc cell membrane receptor, known
as an erythropoietin receptor (EPO-R) (Lodish et al.,
1995). EPO-R is a member of the hematopoietic cytokine
receptor superfamily and consists of an intracellular,
* Correspondence: humeratariq@yahoo.com
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a transmembrane, and an extracellular EPO-binding
domain (D’Andrea et al., 1991).

Studies on the EPO receptor are still of a larger interest
after the findings that the EPO-R is expressed not only
in hematopoietic but also in nonhematopoietic cells and
tissues (Farrell and Lee, 2004). Early studies on EPO-R
showed that this receptor is only expressed in cells of the
erythroid lineage, emphasizing that the action of EPO is
limited to red blood cell manufacturing, while further
studies divulged the wide expression of the EPO-R,
increasing the likelihood of extra-hematopoietic effect
of EPO (Wang et al., 2014). The detection of EPO-R
mRNA in the brain, heart, retinal, skeletal, muscle, and
kidney cells makes it a promising target to study its untold
functions (Morishita et al., 1997; Wu et al., 1999; Noguchi
et al., 2008; Hu et al., 2013).
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Deﬁning the exact function of a protein, especially
with multifunctional behavior, is not easy in vivo due to
the occurrence of numerous other interacting molecules.
Detailed knowledge of the 3D structure of a protein is
essential for the proper understanding of the biological
function(s) of protein (Bork and Koonin, 1998; Attwood,
2000). Several posttranslation modifications (PTMs), e.g.,
N- or O-glycosylation, acetylation, sulfation, methylation,
and phosphorylation, could modify the 3D structure of a
protein. Among all PTMs, O-linked phosphorylation and
glycosylation of serine/threonine (Ser/Thr) residues of a
protein are extremely dynamic and help in modulating
the function of proteins by temporarily affecting their 3D
structure (Figure 1A).
Alternating O-glycosylation and phosphorylation and
their interplay at the same or neighboring residues are
known as the yin–yang phenomenon (Wells et al., 2004).
The amino acid residues (Ser/Thr) where this interplay
occurs are termed as yin–yang sites. These yin–yang sites
can be predicted reliably using various programs based
on artiﬁcial neural networks. However, conserved sites
with high phosphorylation and low O-glycosylation are
considered false negative yin–yang sites. This alternating
phosphorylation and O-glycosylation phenomenon has
been observed in many different proteins that influence
the localization, folding, solubility, biological half-life,
antigenicity, and cell-to-cell interaction of the protein
(Love and Hanover, 2005; Jahangir et al., 2014; Wang et
al., 2016).

Ligand-induced intracellular phosphorylation of the
EPO-R is an experimentally proven phenomenon that
plays an important role in the regulation of hematopoietic
and nonhematopoietic downstream signaling pathways
(Sawyer and Penta, 1996; Elliott et al., 2006; FunakoshiTago et al., 2016). The intention for selecting the EPO-R
as a model protein for this study was to involve this
receptor in mediating multiple effects by its single ligand.
This study was conducted to reveal the behavior of EPO
as a multifunctional protein, based on the modiﬁcation
potential of its receptor, particularly concerning
alternating O-glycosylation and phosphorylation at Ser,
Thr, and tyrosine (Tyr) residues.
In the present study, how these two PTMs that might
affect the functions of EPO-R was examined. There may
be a direct or reciprocal interplay between O-glycosylation
and phosphorylation at Ser/Thr residues that modulates
the function of EPO receptor. Previously, it was considered
that only O-glycosylation modifications at Ser/Thr
residues have any association with phosphorylation on the
same residues. However, in this study, the role of a newly
identified phenomenon in which Tyr phosphorylation
also interacts with O-glycosylation (Ande et al., 2009)
was discussed (Figure 1B). Furthermore, the presence of
certain favorable or nonfavorable amino acids around the
Ser/Thr residues of EPO-R that may affect the glycosylation
potential of these residues was also discussed.

Figure 1. Hypothetical illustration of protein modification, potentially created by the O-glycosylation
and phosphorylation. (A) If sugar or phosphate group is added or removed from a protein, its 3D
structure could potentially be changed. (B) Showing the interplay between glycosylation and Tyr
phosphorylation.
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2. Materials and methods
2.1. Sequences retrieval and selection
For the prediction of yin–yang sites, O-glycosylation,
and phosphorylation modification of human EPO-R, the
sequence was obtained from the Swiss-Prot sequence
database with the entry name of EPOR_HUMAN
(accession number NP_000112). To select the orthologs
of EPO-R gene, a BLAST search was performed using the
human EPO-R sequence as a reference. The NCBI-BLAST
database was used with all default parameters. From the
obtained search results, five mammal sequences with high
similarity indexes were selected. The selected sequences
were: Sus scrofa (wild boar), Canis lupus (domestic dog),
Mus musculus (house mouse), Rattus norvegicus (brown
rat), and Macaca mulatta (rhesus monkey) (Table 1).
ClustalW software was used to locate the position of
conserved Ser/Thr and Tyr residues among the mammalian
EPO-R protein sequences (Thompson et al., 1994).
2.2. Phosphorylation prediction method
For prediction of phosphorylation sites in human EPO-R,
Netphos 2.0 (http://www.cbs.dtu.dk/services/NetPhos-2.0/
or http://www.cbs.dtu.dk/services/NetPhos) was used. The
threshold value used to predict phosphorylation was 0.5.
This software retrieves the data of protein phosphorylation
modification through phosphoBase 2.0 (Kreegipuu et al.,
1999; Huang et al., 2005). These methods are based on
artificial neural networks that consist of a large number
of interconnected processing nodes (neurons) that receive
numerous inputs and give a single output generated on the
strengths of multiple inputs (Kreegipuu et al., 1999). For
the prediction of kinase potential to phosphorylate Ser, Thr,
and Tyr residues of human EPO-receptor, the NetphosK
1.0 (http://www.cbs.dtu.dk/services/NetPhosK/) and
KinasePhos 2.0 (http://kinasephos2.mbc.nctu.edu.tw/)
servers were used. Computer-based methods predict the
PTM potential of amino acids under the perspective for
regulation of protein with reliable accuracy (Nielsen et al.,
1999).

2.3. Prediction of yin–yang and O-glycosylation sites of
human EPO-R
The potential of human EPO-R for the presence of yin–yang
and O-glycosylation sites was measured through YinOYang
1.2 (http://www.cbs.dtu.dk/services/YinOYang/) software.
This software also employs a panel of neural networks to
experimentally determine O-glycosylation attachment
sites by recognizing the amino acid sequence context
and surface accessibility of kinases to these sites. The
threshold value used by this software varies depending on
the accessibility of amino acid residues to the surface of
protein (Gupta et al., 1999). The YinOYang 1.2 prediction
technique was 72.5% efficient for glycosylated sites and
79.5% efficient for nonglycosylated site in a validation
test, verifying the correlation coefficient of Matthews: 0.22
on the original data, and 0.84 on the amplified data set
(Matthews, 1975).
3. Results
3.1. Yin–yang and of O-glycosylation predicted sites of
human EPO-R
YinOYang 1.2 prediction outcome showed that human
EPO-R contains 19 amino acids having potential for
O-glycosylation modification, and five amino acids that
may serve as potential yin–yang sites (Table 2; Figure 2).
Out of these five yin–yang sites, three were predicted in the
extracellular domain, while two sites were predicted in the
cytoplasmic domain of EPO-R (Figure 3). The cytoplasmic
domain is catalytically more important, as it serves as a
docking site for proteins involved in the signaling cascade
triggered by erythropoietin. More glycosylation and
phosphorylation sites were predicted in this domain and
might have some significance in modulating the function
of EPO-R. We propose that these predicted yin–yang sites
have an alternate interaction with phosphorylation and
O-glycosylation on the same and neighboring residues,
which might contribute significantly in exerting different
effects of EPO on different tissues.

Table 1. Different mammalian species (orthologs) selected for multiple amino acid sequence alignment of the EPO
receptor.
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Mammalian species

Sequence IDs

Bits scores

% Identity

E-value

Homo sapiens

NP_000112.1

976

100

0.0

Macaca mulatta

XP_001105833.1

945

97

0.0

Sus scrofa

NP_999457.1

780

85

0.0

Canis lupus familiaris

NP_001041576.1

729

83

0.0

Mus musculus

NP_034279.3

728

82

0.0

Rattus norvegicus

NP_058698.2

726

81

0.0
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Table 2. Predicted O-glycosylation modification and yin–yang sites of the human EPO receptor. (Ser = Serine and Thr =Threonine)
O-glycosylation sites

Yin–yang sites

False negative yin–yang sites

Ser 90,103, 160, 212, 357, 376, 379, 380,
382,383, 444, 478, 483

Ser 160,380, 444

Ser 151, 183, 221, 248, 263, 266, 310,398, 437, 440,
445, 448, 456

Thr 89, 100, 147, 192, 299, 441

Thr 89,147

Thr 73, 219, 274,296

Figure 2. Graphical presentation of phosphorylation and O-glycosylation sites modiﬁcation potential
of human EPO-R. (A) Phosphorylation potential of Thr, Ser, and Tyr is denoted by green, blue, and red
vertical lines, respectively. (B) Potential of Ser/Thr residue for O-glycosylation modification is indicated
by vertical green lines and yin–yang sites in human EPO-R are denoted by red asterisks.

3.2. False negative yin–yang sites in human EPO-R
A conserved site with high phosphorylation but low
O-glycosylation potential (close to the threshold value)
is considered a false negative yin–yang site. The reason
for considering these sites false negative is that if a kinase
enzyme could access them, then there is a possibility that
glycosylation enzymes also access these sites (Kamemura
et al., 2002). In EPO-R, 13 Ser and 4 Thr residues seemed
to be false negative yin–yang positions (Table 2), as these
residues showed a potential for O-glycosylation very close
to threshold value and a high potential for phosphorylation
modification. These false-negative yin–yang residues were
also conserved in most mammalian species (Figure 4).

3.3. Predicted phosphorylation sites of human EPO-R
Phosphorylation prediction results indicate that human
EPO-R has high potential for phosphorylation (Figure 2B).
A total of 34 amino acids were predicted to be modified
through phosphorylation and among these 34 amino acids
20 were Ser, 9 were Thr, and 5 were Tyr (Table 3). There
are eight reported Tyr phosphorylation sites in EPO-R
(Klingmuller, 1997). Among these 8 Tyr phosphorylation
sites, 5 sites (Y343, Y401, Y443, Y461, and Y464) were
predicted correctly but 3 sites (Y429, Y431, and Y479)
were not predicted for phosphorylation by YingOYang
1.2. Netphos 2.0 predicted 34 possible phosphorylation
sites, and out of these 34 sites 15 are fully conserved and
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Figure 3. Schematic representation of predicted O-glycosylation, phosphorylation, and yin– yang sites of
human EPO-R. (A) In the extracellular domain, eight glycosylation and three yin–yang sites were predicted,
represented by hexagons, solid hexagons, and triangles, respectively. (B) The cytoplasmic domain only had
two yin–yang sites, but more glycosylation and phosphorylation sites were predicted. A total of nineteen
glycosylation sites were predicted, but only a few important phosphorylation sites (triangles) that may crosstalk with nearby O-glycosylation residue are shown here. Triangles with solid lines show the phosphorylation
site predicted through Netphos 2.0, and triangles with dotted lines show the phosphorylation sites predicted
through Kinase logos.

4 sites are partially conserved, showing higher potential
for phosphorylation. These 15 sites comprise Ser 160, 183,
248, 263, 310, 398, 437, 440, 444, 445, 448, and Thr 73, 89,
219, and 274 (Figure 4).
3.4. Validity of predicted results
Advancement in bioinformatics has made it possible to
evaluate the validity of the predicted posttranslational
modifications. If predicted amino acids in specific proteins
for particular PTM remain conserved, confidence in the
predicted results will be increased. If the sites are not
conserved over the period of evolution, the predicted results
can be questioned. By applying this strategy, a sequence
of human EPO-R was aligned with other mammalian
species. Among all the yin–yang sites predicted in EPO-R,
Ser 160, 380, and 444 and Thr 89 were fully conserved in
mammals, but Thr 147 was present only in humans and
absent in all other selected species. Among 17 yin–yang
sites that were predicted as false negative sites, 13 were
conserved, 2 were semiconserved, and 2 sites showed the
conserved substitution as shown in Figure 4.
The impact of a particular amino acid in the close
vicinity of potential O-glycosylation site has already been
established (Thanka Christlet and Veluraja, 2001). The
association of favorable residues for glycosylation with
predicted sites also validates the proposed results (Table
4). Around the first predicted yin–yang site (Thr 89),
conserved proline residue at both the −4 and +5 positions,
conserved alanine at the −2 position, and conserved Ser at
+1 and +2 positions were observed. Similarly, Thr 147, a
second predicted yin–yang site in the extracellular domain
of EPO-R, had Proline at the −2,−3, and +1 positions
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(Table 4), which is a pattern of amino acid that favors
O-glycosylation. This fact supports Thr 147’s potential
as a yin–yang site. All other predicted yin–yang sites did
not have proline in their vicinity except Thr 89, which has
proline at the −4 position. We also found 3 such amino
acids in close vicinity of all other false positive and negative
yin–yang sites that favor glycosylation.
4. Discussion
Erythropoietin exerts multiple effects in different organs
and tissues (Wang et al., 2014). In hematopoietic tissues,
EPO is involved in the cell cycle progression, proliferation,
and differentiation of erythroid progenitor cells. As far as
the nonhematopoietic functions of EPO are concerned,
EPO not only promotes the proliferation and migration
of endothelial cells but it also induces neovascularization.
Preclinical studies have shown that EPO also exerts
cardioprotective effects (Calvillo et al., 2003; Parsa et
al., 2004). With respect to the central nervous system,
both EPO-R and EPO become detectable in the brain of
human embryos 5 weeks after conception (Dame et al.,
2000). EPO-R has also been expressed by neurons and
astrocytes (Bernaudin et al., 1999; Sugawa et al., 2002),
and on these sites EPO exerts both neuroprotective and
neurotrophic effects (Digicaylioglu and Lipton, 2001).
Thus EPO is involved in a variety of functions. However,
mechanisms involved in its multifunctional behavior
are poorly characterized. The role of phosphorylation
of EPO-R in regulating its function has already been
described (Constantinescu et al., 1999). In the present
study, the potential of EPO-R’s amino acid residues to

KAUSAR et al. / Turk J Biol

Figure 4. Multiple sequences alignment of six EPO-R sequences (human, rhesus monkey, wild boar, dog, common rat, and mouse) by
using CLUSTALW software. Figure represents conserved sequences (*), conserved substitution (:), and semiconserved substitution (.).
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Table 3. Predicted phosphorylation sites of human EPO-R.
Extracellular

Transmembrane

Cytoplasmic

Ser

151,160,167,183,221

248

263,266,305,310,380,387,390, 398,437,440,444,445,448,456

Thr

73,89,147,219

274,296,324,342,415

Tyr

343,401,443,460,464
Table 4. Favorable and unfavorable amino acids for glycosylation around the yin–
yang sites. Amino acid sequences, showing the context of (+) and (–) five residues
around the yin–yang sites. Yellow highlighted bold letters represent the yin–yang
sites. Residues that favor glycosylation are highlighted in green, unfavorable residues
are highlighted in red, and residues that neither hinder nor support glycosylation are
highlighted in gray.
Serial. No
1
Positive predicted
Yin Yang sites

False negative
Yin Yang sites

2

Thr 147

3

Ser 160

4

Ser 380

5
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

Ser 444
Thr 73
Ser 151
Ser 183
Thr 219
Ser 221
Ser 248
Ser 263
Thr 274
Ser 266
Thr 296
Ser 310
Ser 398
Ser 437
Ser 440
Ser 445
Ser 448
Ser 456

be phosphorylated and O-glycosylated was explored.
Thirty-four potential sites for phosphorylation and 19
sites for O-glycosylation were found. PTMs might have
a role in regulating the EPO-R signaling event that may
induce the conformational changes affecting protein’s
structure and their 3D configuration. The amino acid
sequence of protein could be investigated by computerassisted methods for the presence of such signals that are
likely to become posttranslationally modiﬁed. Therefore,
predictions based upon the presence of specific amino
acid patterns could become a helpful tool to explore the
modiﬁcations potential and function of proteins (Droit et
al., 2005; Ngounou Wetie et al., 2014).
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Position
Thr 89

Peptide sequences

LPTADTSSFVP

LPPPETPMTSH
YEVDVSAGNGA
GSEASSCSSAL
ISTDYSSGDSQ
LHQAPTARGAV
ETPMTSHIRYE
TECVLSNLRGR
PVSLLTPSDLD
VLLTPSDLDPL
VLALLSHRRAL
WPGIPSPESEF
EGLFTTHKGNF
IPSPESEFEGL
WWSPCTPFTED
PLEVLSERCWG
GASAASFEYTI
LVVSDSGISTD
SDSGISTDYSG
STDYSSGDSQG
YSSGDSQGAQG
AQGGLSDGPYS

Among all known PTMs, the dynamic and regulatory
nature of O-glycosylation and phosphorylation allows
proteins to carry out multiple functions. The alternating
presence of these modiﬁcations was observed in many
different proteins (Cheng and Hart, 2001; Chou et al.,
1995; Medina et al., 1998). For example, it has been
experimentally proved that, in transcription factor Myc,
Thr 58 is alternately phosphorylated and glycosylated for its
regulation (Kamemura et al., 2002). These observations led
to the formation of the yin–yang hypothesis, which states
that there is a complex interplay between O-glycosylation
and phosphorylation on similar and/or adjacent amino
acids of a protein. Phosphorylation of the EPO-R is a
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well observed modification that plays a signiﬁcant role in
the signal transduction and regulation of its action. EPO
binding to the EPO-R triggers homodimerization of two
EPO-R molecules that allows Jak2 molecules to come
closer, and trans- and/or autophosphorylates eight Tyr
residues on the cytoplasmic domain of the EPO-R. The
phosphorylated Tyr residues can serve as docking sites for
recruitment of various proteins, for instance, Ser-homolog
Tyr phosphatase 1 and 2, phosphatidylinositol 3 kinase,
and signal transducer and activator of transcription 5
(Stat5), leading to their phosphorylation and inducing
their corresponding signaling cascade (Constantinescu et
al., 1999).
Previously, it was thought that only phosphorylated
Tyr residues of cytoplasmic domain of EPO-R are involved
in the EPO-induced signaling pathway. However, the
finding that non-Tyr residues (e.g., Ser) are also involved
in controlling EPO-R signaling opens new directions
for exploring the internal mechanisms of EPO action
(Yoon and Watowich, 2003). These researchers suggested
the possible involvement of phosphorylated Ser residue
(rather Tyr) in stimulating the Stat5 signaling pathway,
emphasizing the significance of Ser residues in C-terminal
region of EPO-R. However, theses authors did not mention
the position of the involved Ser residue(s). We predicted
12 potential Ser residues for phosphorylation (305, 310,
380, 387, 390, 398, 437, 440, 444, 445, 448, and 456) in
the C-terminal region EPO-R. Interestingly, all these
Ser residues were conserved in mammals, making them
possible targets for PTMs (Figure 4). Among these, Ser 380
and 444 also showed potential for both phosphorylation
and O-glycosylation modiﬁcation and have been predicted
as yin–yang sites. In the C-terminal region, these two
sites may play a regulatory role through alternating
phosphorylation and O-glycosylation modiﬁcation.
In the EPO-R cytoplasmic region, another important
residue is Ser 478, which showed high potential for
O-glycosylation, and its adjacent Tyr 479, which supports
the differentiation and proliferation of erythroid progenitor
cells in its phosphorylated form. Tyr 479 is a key residue
that supports erythroid colony formation without the
presence of any other Tyr residues (Klingmuller et al.,
1997). However, Tyr 479 seems to have limited potential
for phosphorylation, as Tyr 479 is highly conserved among
mammals and its phosphorylation has also been proven
experimentally (Sulahian et al., 2009). Therefore, this
residue appears to be a false negative phosphorylation site. It
has been suggested that Tyr 479 in its phosphorylated form
is involved in the EPO-dependent EPO-R internalization,
and controls the duration of EPO-induced signaling.
Controlling the duration of signaling is crucial, as this
decides the ultimate final effect of signaling. For example,
when EPO receptor signaling was reduced, it decreased

cell proliferation and increased the terminal differentiation
of erythroid cells (Sulahian et al., 2009). When Ser
478 is modiﬁed by glycosylation, it may block or delay
phosphorylation on Tyr 479. This may result in decreased
cell proliferation and differentiation, while increased
phosphorylation facilitates cell proliferation of erythroid
stem cells. This could be a notable example of the interplay
between Tyr phosphorylation and O-glycosylation at
neighboring residues, which regulates the signaling event
induced by EPO. This complex binary switch between Tyr
phosphorylation and O-glycosylation modiﬁcation seems
to regulate the signaling event induced by EPO.
A complex network of signaling pathways allows
EPO-R to perform multiple functions. However, it is still
unclear how the binding of EPO (a single ligand) molecule
could affect different organs. EPO-R endocytosis is an
efficient way to increase or decrease EPO responsiveness.
Endocytosis is a common process of attenuation
and downregulation of EPO-R. In addition, EPO-R
endocytosis plays a significant role in the clearance of
EPO and therefore regulates its bioactivity (Walrafen et al.,
2005). Only one residue (Ser 248) in the transmembrane
domain showed potential for phosphorylation. When the
amino acids context of Ser 248 was closely analyzed, it had
amino acids in its proximity that favor glycosylation. Thus,
Ser 248 appears to be an important residue because of its
transmembrane position and presence of downstream
lysine-rich region. These observations reveal that this
residue may potentially play a role in EPO-R endocytosis,
degradation, and recycling.
When the sequence of cytoplasmic domain of the
EPO-R was further explored, it was observed that Thr
423, which possesses high phosphorylation potential (data
predicted through KinasePhos 2.0; not shown), is present
near lysine (K 428). The presence of proline at both +1
and −1 positions also supports its glycosylation potential.
Glycosylation at Thr 423 might hinder β-TrCP binding,
an enzyme involved in regulation of the EPO-R that
ubiquitinates at K-428 and ultimately results in recycling
EPO-R to the cell surface (Meyer et al., 2007). However,
phosphorylation on the same residue inhibits the EPO-R
recycling and decreases EPO sensitivity (Gross and
Lodish, 2006). This internalization and ubiquitination of
EPO-R might allow the EPO protein to perform different
functions in a different organ by prolonging or shortening
the signaling phenomenon. Important evidence that Ser/
Thr phosphorylation plays a significant role in controlling
the EPO functions has come from the involvement of
protein kinase C in controlling the EPO-R signaling during
erythroid differentiation and proliferation. Protein kinase
C is a Ser/Thr kinase and its inhibition can reportedly
abrogate EPO-dependent mitosis (von Lindern et al.,
2000).
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The exact mechanism of controlling EPO-R signaling
is not entirely understood. Different aspects still need to
be explored. On the basis of these findings and previously
available data, we propose the involvement of alternating
Ser/Thr O-glycosylation and phosphorylation in controlling
EPO-R signaling. As O-glycosylation of EPO-R is essential
in increasing its sensitivity to EPO, its phosphorylation at
certain residues negates its effects. The interplay between
Tyr phosphorylation and O-glycosylation modification of
neighboring residues may be involved in controlling the

duration of EPO-R signaling. In conclusion, along with
Ser/Thr alternative phosphorylation and O-glycosylation,
Tyr phosphorylation and its interplay with neighboring
glycosylated residues may also play a decisive role in
regulating the EPO-R function. These binary modifications
may help solve many unanswered mechanisms related
to EPO-R ubiquitination, internalization, and recycling
and also its multifunctional behavior under different
hematopoietic and nonheamatopoietic environments.
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